Krystal Biotech Statistics
Total Valuation
KRYS has a market cap or net worth of $4.63 billion. The enterprise value is $4.17 billion.
| Market Cap | 4.63B |
| Enterprise Value | 4.17B |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KRYS has 28.29 million shares outstanding. The number of shares has increased by 8.87% in one year.
| Shares Outstanding | 28.29M |
| Shares Change (YoY) | +8.87% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 12.78% |
| Owned by Institutions (%) | 89.01% |
| Float | 20.55M |
Valuation Ratios
The trailing PE ratio is 425.41 and the forward PE ratio is 143.58.
| PE Ratio | 425.41 |
| Forward PE | 143.58 |
| PS Ratio | 92.65 |
| Forward PS | 18.13 |
| PB Ratio | 6.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 381.73 |
| EV / Sales | 82.31 |
| EV / EBITDA | 233.08 |
| EV / EBIT | 323.57 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.77 |
| Quick Ratio | 17.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.45 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.60% and return on invested capital (ROIC) is -11.82%.
| Return on Equity (ROE) | 1.60% |
| Return on Assets (ROA) | 1.50% |
| Return on Capital (ROIC) | -11.82% |
| Revenue Per Employee | $221,393 |
| Profits Per Employee | $47,738 |
| Employee Count | 229 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KRYS has paid $1.97 million in taxes.
| Income Tax | 1.97M |
| Effective Tax Rate | 15.24% |
Stock Price Statistics
The stock price has increased by +92.60% in the last 52 weeks. The beta is 0.86, so KRYS's price volatility has been lower than the market average.
| Beta (1Y) | 0.86 |
| 52-Week Price Change | +92.60% |
| 50-Day Moving Average | 156.43 |
| 200-Day Moving Average | 127.17 |
| Relative Strength Index (RSI) | 49.34 |
| Average Volume (30 Days) | 399,851 |
Short Selling Information
The latest short interest is 2.17 million, so 7.68% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 7.68% |
| Short % of Float | 10.58% |
| Short Ratio (days to cover) | 4.77 |
Income Statement
In the last 12 months, KRYS had revenue of $50.70 million and earned $10.93 million in profits. Earnings per share was $0.39.
| Revenue | 50.70M |
| Gross Profit | 47.61M |
| Operating Income | -109.73M |
| Pretax Income | 12.90M |
| Net Income | 10.93M |
| EBITDA | 17.90M |
| EBIT | 12.90M |
| Earnings Per Share (EPS) | $0.39 |
Balance Sheet
The company has $532.18 million in cash and $8.09 million in debt, giving a net cash position of $524.08 million or $18.52 per share.
| Cash & Cash Equivalents | 532.18M |
| Total Debt | 8.09M |
| Net Cash | 524.08M |
| Net Cash Per Share | $18.52 |
| Equity / Book Value | 778.64M |
| Book Value Per Share | 27.52 |
| Working Capital | 554.82M |
Cash Flow
In the last 12 months, operating cash flow was -$88.80 million and capital expenditures $88.20 million, giving a free cash flow of -$603,000.
| Operating Cash Flow | -88.80M |
| Capital Expenditures | 88.20M |
| Free Cash Flow | -603,000 |
| FCF Per Share | -$0.02 |
Margins
Gross margin is 93.90%, with operating and profit margins of -216.43% and 21.56%.
| Gross Margin | 93.90% |
| Operating Margin | -216.43% |
| Pretax Margin | 25.44% |
| Profit Margin | 21.56% |
| EBITDA Margin | 35.31% |
| EBIT Margin | 25.44% |
| FCF Margin | -1.19% |
Dividends & Yields
KRYS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.87% |
| Shareholder Yield | -8.87% |
| Earnings Yield | 0.23% |
| FCF Yield | -0.01% |
Analyst Forecast
The average price target for KRYS is $165.00, which is 0.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $165.00 |
| Price Target Difference | 0.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 73.32% |
| EPS Growth Forecast (5Y) | 102.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRYS has an Altman Z-Score of 71.43 and a Piotroski F-Score of 4.
| Altman Z-Score | 71.43 |
| Piotroski F-Score | 4 |